Osteoporosis: Medical and Surgical Options

  • Abraham M. Obuchowski
  • Aleksandar Curcin
  • John P. Kostuik

Abstract

Osteoporosis is a common bone disease affecting nearly 200 million individuals worldwide. In the United States alone, there are more than 1.5 million osteoporotic fractures annually, including 250,000 hip, 250,000 wrist, and 500,000 to 700,000 vertebral fractures.1 Although vertebral fractures are much more common, hip fractures are the most devastating, with a 12 to 20% mortality rate in the first 4 to 6 months after fracture.2 Up to 25% of patients with hip fractures require long-term nursing care, and only one third of patients with hip fractures return to prefracture activity levels. Current estimates indicate that 10 million Americans already have the disease and an additional 18 million have osteopenia, putting them at risk of developing the disease. Of this at-risk population, 80% are women. However, 30% of hip fractures and 20% of vertebral fractures occur in men.1

Keywords

Bone Mineral Density Vertebral Fracture Peak Bone Mass Bone Mineral Density Testing Indirect Decompression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Riggs BL, Melton LJ, III. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995; 17(5 suppl):505S–511S.PubMedCrossRefGoogle Scholar
  2. 2.
    Riggs BL, Warmer HW, Dunn WL, et al. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981; 67(2):328–335.PubMedCrossRefGoogle Scholar
  3. 3.
    Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12(l):24–35.PubMedCrossRefGoogle Scholar
  4. 4.
    Johnell O. The socioeconomic burden of fractures: today and in the 21st century. Am J Med 1997; 103(2A):20S-25S.PubMedCrossRefGoogle Scholar
  5. 5.
    Consensus development conference: prophylaxis and treatment of osteoporosis. Osteoporos Int 1991; 1(2):114–117.Google Scholar
  6. 6.
    Consensus Development Conference: prophylaxis and treatment of osteoporosis. Am J Med 1991; 90(1):107–110.Google Scholar
  7. 7.
    Kanis JA, Melton LJ, III, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9(8):1137–1141.PubMedCrossRefGoogle Scholar
  8. 8.
    Riggs BL, Melton LJ, III. Involutional osteoporosis. N Engl J Med 1986; 314(26):1676–1686.PubMedCrossRefGoogle Scholar
  9. 9.
    Young D, Hopper JL, Nowson CA, et al. Determinants of bone mass in 10- to 26-year-old females: a twin study. J Bone Miner Res 1995; 10(4)558–567.PubMedCrossRefGoogle Scholar
  10. 10.
    Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332(12):767–773.PubMedCrossRefGoogle Scholar
  11. 11.
    Eisman JA. Vitamin D receptor gene alleles and osteoporosis: an affirmative view [editorial]. J Bone Miner Res 1995; 10(9):1289–1293.PubMedCrossRefGoogle Scholar
  12. 12.
    Tokita A, Kelly PJ, Nguyen TV, et al. Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover. J Clin Endocrinol Metab 1994; 78(6):1461–1466.PubMedCrossRefGoogle Scholar
  13. 13.
    Ryan PJ, Fogelman I. The bone scan: where are we now? Semin Nucl Med 1995; 25(2):76–91.PubMedCrossRefGoogle Scholar
  14. 14.
    Engelke K, Grampp S, Gluer CC, et al. Significance of QCT bone mineral density and its standard deviation as parameters to evaluate osteoporosis. J Comput Assist Tomogr 1995; 19(1):111–116.PubMedCrossRefGoogle Scholar
  15. 15.
    Bauer DC, Gluer CC, Genant HK, et al. Quantitative ultrasound and vertebral fracture in postmenopausal women. Fracture Intervention Trial Research Group. J Bone Miner Res 1995; 10(3):353–358.PubMedCrossRefGoogle Scholar
  16. 16.
    Kanis JA, WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporosis Int 1994; 4(6):368–381.CrossRefGoogle Scholar
  17. 17.
    LeBoff MS. Metabolic bone disease. In: Kelley WN, Ruddy S, Harris ED, Jr, et al. eds. Textbook of Rheumatology. 5th ed. Philadelphia: WB Saunders Co; 1997:1563–1580.Google Scholar
  18. 18.
    Hayes WC, Piazza SJ, Zysset PK. Biomechanics of fracture risk prediction of the hip and spine by quantitative computed tomography. Radiol Clin North Am 1991; 29(1):1–18.PubMedGoogle Scholar
  19. 19.
    Gregg EW, Cauley JA, Seeley DG, et al. Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1998; 129(2):81–88.PubMedGoogle Scholar
  20. 20.
    Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998; 280(7):605–613.PubMedCrossRefGoogle Scholar
  21. 21.
    Reid IR, Ames RW, Evans MC, et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 1995; 98(4):331–355.PubMedCrossRefGoogle Scholar
  22. 22.
    Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327:1637–1642.PubMedCrossRefGoogle Scholar
  23. 23.
    Recker RR, Hinders S, Davies KM, et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 1996; 11(12):1961–1966.PubMedCrossRefGoogle Scholar
  24. 24.
    Civitelli R, Gonnelli S, Zacchei F, et al. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 1988; 82(4):1268–1274.PubMedCrossRefGoogle Scholar
  25. 25.
    Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282(7):637–645.PubMedCrossRefGoogle Scholar
  26. 26.
    Denis F. The three column spine and its significance in the classification of acute thoracolumbar spinal injuries. Spine 1983; 8:817–831.PubMedCrossRefGoogle Scholar
  27. 27.
    Lyritis GP, Mayasis B, Tsakalakos N, et al. The natural history of the osteoporotic vertebral fracture. Clin Rheumatol 1989; 8(suppl 2): 66–69.PubMedCrossRefGoogle Scholar
  28. 28.
    White AA, Panjabi MM. Clinical Biomechanics of the Spine. 2nd ed. Philadelphia: JB Lippincott Co, 1990.Google Scholar
  29. 29.
    Garfin SR, Blair B, Eismont FJ, et al. Thoracic and upper lumbar spine injuries. In: Browner BD, Jupiter JB, Levine AM, et al. eds. Skeletal Trauma: Fractures, Dislocations, Ligamentous Injuries. 2nd ed. Philadelphia: WB Saunders Co; 1998:947–1034.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Abraham M. Obuchowski
  • Aleksandar Curcin
  • John P. Kostuik

There are no affiliations available

Personalised recommendations